Advanced search
Publication Cover
Future Neurology Volume 14, 2019 - Issue 2
Submit an article Journal homepage
1,041
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Neuromyelitis Optica Spectrum Disorder with Radiological Manifestation of Multiple Sclerosis in the First Brain MRI: a Case Report

Abdorreza Naser Moghadasi1 Assistant Professor of Neurology; Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, IranView further author information
&
Seyed Mohammad Baghbanian2 Assistant Professor of Neurology, Neurology Department; Booali sina Hospital, Mazandaran University of Medical Sciences; Pasdaran Boulevard, Sari, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8138-7504View further author information
ORCID Icon
Article: FNL15 | Received 11 Sep 2018, Accepted 13 Mar 2018, Published online: 28 May 2019

References

  • WingerchukDM, BanwellB, BennettJLet al.International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology85(2), 177–189 (2015).
  • NarayanR, SimpsonA, FritscheKet al.MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Mult. Scler. Relat. Disord.25, 66–72 (2018).
  • KimHJ, PaulF, Lana-PeixotoMAet al.MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology84(11), 1165–1173 (2015).
  • PittockSJ, WeinshenkerBG, LucchinettiCFet al.Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch. Neurol.63(7), 964–968 (2006).
  • MatthewsL, MarascoR, JenkinsonMet al.Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology80(14), 1330–1337 (2013).
  • NakamuraM, MisuT, FujiharaKet al.Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult. Scler.15(6), 695–700 (2009).
  • KiraJI. Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others?Mult. Scler.23(9), 1300–1302 (2007).
  • JariusS, ProbstC, BorowskiKet al.Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J. Neurol. Sci.291, 52–56 (2010).
  • BonnanM, ValentinoR, DebeugnySet al.Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J. Neurol. Neurosurg. Psychiatry89(4), 346–351 (2018).
  • TrebstC, JariusS, BertheleAet al.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J. Neurol.261(1), 1–16 (2014).
  • MatthewsL, MarascoR, JenkinsonMet al.Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology80(14), 1330–1337 (2013).
  • KimW, ParkMS, LeeSHet al.Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult. Scler.16(10), 1229–1236 (2010).
  • LiaoMF, ChangKH, LyuRKet al.Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients. BMC Neurol.14, 218 (2014).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.